+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Genders
ID06924944

Study on Vision Outcomes After Cataract Surgery Using Bilateral Clareon Vivity Lenses in Patients with Previous Myopic Laser Eye Surgery

Led by Utah Eye Centers · Updated on 2025-04-13

35

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What this Trial Is About

Millions of people who have had laser vision correction surgery are interested in maintaining their independence from glasses as they develop presbyopia and cataracts. However, previous refractive surgery can make selecting the right intraocular lenses IOLs challenging and may lead to unpredictable visual outcomes. Researchers are evaluating the clinical results of using Clareon Vivity and Vivity Toric lenses in patients who previously had myopic refractive surgery to better understand their effectiveness. Participants in this observational study will undergo cataract surgery treated with bilateral Clareon Vivity toric and non-toric IOLs. The study focuses on patients who have had uncomplicated post-refractive myopic surgery, such as LASIK or PRK, possibly with one enhancement treatment. The lenses are designed to provide effective distance, intermediate, and near vision while minimizing visual disturbances related to surgery. During the study, researchers will measure binocular photopic uncorrected distance visual acuity at three months after surgery, along with uncorrected vision at intermediate and near distances. The study monitors vision outcomes and evaluates how well the lenses perform in patients with prior refractive surgery. Participants will be followed for at least three months to assess these visual measures and overall results.

CONDITIONS

Brief Title

Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Research Team

R

Rachel Buchanan

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here